SummitTX Capital’s Drugs Made In America Acquisition II Corp Right DMIIR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$5.62K Buy
+100,000
New +$7.79K ﹤0.01% 846

Other funds holding DMIIR

SummitTX Capital's DMIIR Position: Q3 2026 in Review

SummitTX Capital opened a new position in Drugs Made In America Acquisition II Corp Right (DMIIR) in Q3 2026: 100,000 shares worth $5.62K. The stake represents ﹤0.01% of the portfolio and ranks #846 among its holdings.

64 funds tracked by Wall St. Rank hold DMIIR as of Q3 2026.

  • SummitTX Capital held 100,000 shares of Drugs Made In America Acquisition II Corp Right worth $5.62K as of Q3 2026.
  • Drugs Made In America Acquisition II Corp Right was a new SummitTX Capital position in Q3 2026.
  • Drugs Made In America Acquisition II Corp Right made up ﹤0.01% of SummitTX Capital's portfolio in Q3 2026, its #846 holding.
  • 64 funds tracked by Wall St. Rank held Drugs Made In America Acquisition II Corp Right as of Q3 2026.

Based on SummitTX Capital's 13F filing for Q3 2026, filed 16 Nov 2026.